Conexeu Sciences (CNXU) Financials: Revenue & Earnings
$82.79M
Market Cap
—
P/E
—
Forward P/E
—
Score
CNXU price $2.94 -0.01 -0.51%
CNXU fair value Not meaningful. Price $2.94.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-09-14 | -0.29 | -0.10 | — | — |
| 2026-06-15 | -0.11 | -0.11 | — | — |
| 2026-03-26 | -0.09 | — | — | — |
| 2026-02-03 | — | — | — | — |
Yield —. Payout ratio —. Frequency —.
Safety score 34/100 · At risk. Payout ratio is not reported, so this part stays neutral. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. Yield is unknown, so this part stays neutral.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-15 | Purcell Lynn Sebastian | Buy | 166.67K | $3.00 | 500.00K |
| 2026-10-15 | Purcell Lynn Sebastian | Buy | 166.67K | $3.00 | 500.00K |
| 2026-09-25 | Bogart David Robert | Buy | 750.00K | $0.00 | 750 |
| 2026-09-25 | Bogart David Robert | Sell | 750.00K | $0.00 | 750 |
| 2026-09-14 | Sharpe Jeffrey Nathan | Buy | 500.00K | $0.00 | 500 |
| 2026-09-14 | Sharpe Jeffrey Nathan | Sell | 500.00K | $0.00 | 500 |
| 2026-09-04 | Purcell Lynn Sebastian | Sell | 217.61K | $2.30 | 500.50K |
| 2026-09-04 | Purcell Lynn Sebastian | Buy | 217.61K | $2.30 | 500.50K |
| 2026-09-04 | Purcell Lynn Sebastian | Buy | 217.61K | $2.30 | 500.50K |
| 2026-06-18 | Purcell Lynn Sebastian | Buy | 202.50K | $0.80 | 162.00K |
| 2026-06-18 | Purcell Lynn Sebastian | Buy | 202.50K | $2.30 | 465.75K |
| 2026-06-18 | Purcell Lynn Sebastian | Sell | 202.50K | $0.80 | 162.00K |
| 2026-06-18 | Wright Michael G. | Buy | 250.00K | $0.00 | 250 |
| 2026-06-18 | Wright Michael G. | Sell | 250.00K | $0.00 | 250 |
| 2026-06-15 | Costa Andrew | Other | 50.00K | $2.30 | 115.00K |
| 2026-06-15 | Burke April Lynn | Other | 50.00K | $2.30 | 115.00K |
| 2026-06-15 | Bastiani-Posner Ana Lucia | Other | 50.00K | $2.30 | 115.00K |
| 2026-06-09 | Chavez-Munoz Claudia Itze | Other | 50.00K | $0.40 | 20.00K |
| 2026-05-26 | Wright Michael G. | Buy | 400.00K | $0.00 | 400 |
| 2026-05-26 | Wright Michael G. | Sell | 400.00K | $0.00 | 400 |
| 2026-05-22 | Sharpe Jeffrey Nathan | Buy | 500.00K | $0.00 | 500 |
| 2026-05-22 | Sharpe Jeffrey Nathan | Sell | 500.00K | $0.00 | 500 |
| 2026-05-14 | Lorenc Zbigniew Paul | Buy | 11.18K | — | — |
| 2026-05-11 | Wright Michael G. | Other | 0 | — | — |
| 2026-05-11 | Wright Michael G. | Other | 0 | — | — |
| 2026-05-11 | Wright Michael G. | Other | 900.00K | $0.00 | 900 |
| 2026-05-11 | Bogart David Robert | Other | 0 | — | — |
| 2026-05-11 | Bogart David Robert | Other | 0 | — | — |
| 2026-05-11 | Bogart David Robert | Other | 1.00M | $0.00 | 1.00K |
| 2026-05-11 | Farberg Aaron Solomon | Other | 0 | — | — |
| 2026-05-11 | Pilcher Brian Keith | Other | 0 | — | — |
| 2026-05-11 | Lorenc Zbigniew Paul | Other | 0 | — | — |
| 2026-05-11 | Chavez-Munoz Claudia Itze | Other | 0 | — | — |
| 2026-05-11 | Sharpe Jeffrey Nathan | Other | 0 | — | — |
| 2026-05-11 | Sharpe Jeffrey Nathan | Other | 1.50M | $0.00 | 1.50K |
| 2026-05-11 | Inouye Stephen Douglas | Other | 0 | — | — |
| 2026-05-11 | Harrison Miles David | Other | 0 | — | — |
| 2026-05-11 | Harrison Miles David | Other | 0 | — | — |
| 2025-10-01 | Pilcher Brian Keith | Other | 100.00K | $0.40 | 40.00K |
| 2025-06-09 | Wright Michael G. | Other | 50.00K | $0.40 | 20.00K |
| 2025-06-09 | Bogart David Robert | Other | 50.00K | $0.40 | 20.00K |
| 2025-06-09 | Inouye Stephen Douglas | Other | 75.00K | $0.40 | 30.00K |
| 2025-01-21 | Wright Michael G. | Other | 78.59K | $0.80 | 62.88K |
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Conexeu Sciences Inc. (CNXU) trades at $2.94, with a market cap of $82.79M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn
$82.79M
Market Cap
—
P/E
—
Forward P/E
—
Score